Mircea Despa, PhD, leads the Smart Device Team, part of the Device Innovation Group, at BD Technologies and Innovation. With BD for over 11 years, Dr Despa oversees Digital Health R&D, spanning from early-stage opportunity assessment to evidence generation through clinical studies. Under his leadership, the group develops prototype interconnected disease management systems, composed of any combination of hardware, software and data algorithms, designed using behavioural science principles. Dr Despa holds a PhD in Engineering Sciences and MS and BS degrees in Chemical Engineering.
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.